Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study
Ahmed Hosny(Brigham and Women's Hospital), Raymond H. Mak(Brigham and Women's Hospital), Jack M. Qian(Brigham and Women's Hospital), Danielle S. Bitterman(Brigham and Women's Hospital), Anurag Saraf(Dana-Farber Brigham Cancer Center), Paul J. Catalano(Computational Physics (United States)), David Kozono(Dana-Farber Cancer Institute), Itai Pashtan(Brigham and Women's Hospital), Subha Perni(Dana-Farber Brigham Cancer Center), Hannah Roberts(Dana-Farber Brigham Cancer Center), Luke Peng(Dana-Farber Brigham Cancer Center), David C. Christiani(Harvard University), Zezhong Ye(Brigham and Women's Hospital), Hugo J.W.L. Aerts(Maastro Clinic), Christian V. Guthier(Brigham and Women's Hospital), Benjamin H. Kann(Brigham and Women's Hospital)
Cited by 70
Related Papers
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures
|Biostatistics|2014|1.8k
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
|New England Journal of Medicine|2012|1.1k
Artificial intelligence in radiation oncology
|Nature Reviews Clinical Oncology|2020|399